Characterization of a murine monoclonal antibody specific for swine β1 integrin

Xenotransplantation

Volumn 5, Issue 1, 1998, Pages 75-83

  Richard, Christelle ^a   Thibaudeau, Karen ^a,b   Charreau, Béatrice ^a   Loirat, Marie Jeanne ^b   Naulet, Jeanne ^a   Blanchard, Dominique ^b   Soulillou, Jean Paul ^a   Bouhours, Jean François ^a,c  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c HÔTEL DIEU   (France)

Author keywords

Endothelial cell; Integrin; Monoclonal antibody; Platelet; Swine; Xenotransplantation

Indexed keywords

INTEGRIN; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL INTERACTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SWINE; THROMBOCYTE;

EID: 0031931435     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1998.tb00012.x     Document Type: Article

References (37)

1. PLATT JL, VERCELLOTI GM, DALMASSO AP, MATAS AJ, BOLMAN RM, NAIARIAN JS, BACH FH. Transplantation of discordant xenografts: A review of progress. Immunol Today 1990; 11:450.
2. GOOD AH, COOPER DCK, MALCOLM AJ, IPPOLITO RM, KOREN E, NEETLING FA, YE Y, ZUHDI N, LAMONTAGNE LR. Identification of carbohydrate structures which bind human anti-porcine antibodies: Implications for discordant xenografting in man. Transplant Proc 1992; 24:559.
3. SANDRIN MS, MCKENZIE IFC. Gaĺ(1,3)gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev 1994; 141:169.
4. GALILI U, TIBELL A, SAMUELSSON B, RYDBERG L, GROTH CG. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995; 59:1549.
5. BOUHOURS D, POURCEL C, BOUHOURS JF. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Galα1-3Gal), blood group H determinant and N-Glycolylneuraminic acid. Glycoconjugate J 1996; 13:947.
6. HOLZKNECHT ZE, PLATT JL. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies. J Immunol 1995; 154:4565.
7. COOPER DCK, KOREN E, ORIOL R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141:31.
8. LEVENTHAL JR, DALMASSO AP, CROMWELL JW, PLATT JL, MANIVEL CJ, BOLMAN-MORTON R, MATAS AJ. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55:1345.
9. TEARLE RG, TANGE, MJ, ZANNETTINO ZL, KATERELOS M, SHINKEL TA, VAN DENDEREN BJW, LONIE AJ, LYONS I, NOTTLE MB, Cox T, BECKER C, PEURA AM, WIGLEY PL, CRAWFORD RJ, ROBINS AJ, PEARSE MJ, D'APICE AJF. The α-1,3-galactosyltransferase knockout mouse. Transplantation 1996; 61:13.
10. SHARMA A, OKABE J, BIRCH P, MCCLELLAN SB, MARTIN MJ, PLATT JL, LOGAN JS. Reduction in the level of Gal-(α1,3)Gal in transgenic mice and pigs by expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93:7190.
11. FODOR WL, WILLIAMS BL, MATIS LA, MAORI JA, ROLLINS SA, KNIGHT JW, VELANDER W, SQUINTO SP. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91:11153.
12. MCCURRY, KOOYMAN D, ALVARADO CG, COTTERELL AH, MARTIN MJ, LOGAN JS, PLATT JL. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1:423.
13. WHITE DJG, LANGFORD GA, COZZI E, YOUNG VJ. Protective effects of human DAF in transgenic pigs. Xenotransplantation 1995; 3:48.
14. BACH FH, WINKLER H, FERRAN C, HANCOCK WW, ROBSON SC. Delayed xenograft rejection. Immunol Today 1996:17:379.
15. BLANCHARD D, THIBAUDEAU K, SOULILLOU JP. Porcine antigenie targets for human natural antibodies. Xeno 1995; 3:57.
16. THIBAUDEAU K, BORCHE L, SOULILLOU JP, BLANCHARD D. Characterization of porcine platelet glycoproteins recognized by human natural "anti-Gal" antibodies. Blood 1996; 87:4636.
17. WARREN JB. The Endothelium, an introduction to current research. New-York: Wiley-Liss, 1990, pp. 263-272.
18. BOUHOURS JF, RICHARD C, RUVOEN N, BARREAU N, NAULET J, BOUHOURS D. Characterization of a polyclonal anti-Galα1-3Gal antibody from hen eggs. Glycoconjugate J 1998; 15:95.
19. JOHANSSON S, FORSBERG E, LUNDGREN B. Comparison of fibronectin receptors from rat hepatocytes and fibroblasts. J Biol Chem 1987; 262:7819.
20. DELISSER HM, NEWMAN PJ, ALBELDA SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994; 15:490.
21. ARGRAVES WS, SUZUKI S, ARAI H, THOMPSON K, PIERSCHBACHER MD, RUOSLAHTI E. Amino acid squence of the human fibronectin receptor. J Cell Biol 1987; 105:1183.
22. TAKADA Y, HEMLER ME. The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GPIa): Homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 1989; 109:397.
23. 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: Molecular and functional characterization. Blood 1994; 84:3734.
24. HEMLER ME, HUANG C, SCHWARZ. The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight Β subunit. J Biol Chem 1987; 262:3300.
25. HYNES RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69:11.
26. SUN QH, DELISSER HM, ZUKOWSKI MM, PADDOCK C, ABELDA SM, NEWMAN PJ. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J. Biol Chem 1996; 271:11090.
27. AKIYAMA SK, YAMADA SS, YAMADA KM. Analysis of the role of glycosylation of the human fibronectin receptor. J Biol Chem 1989; 264:18011.
28. RINGEARD S, HARB J, GAUTHIER F, MENANTEAU J, MEFLAH K. Altered glycosylation of α(s)Β1 integrins from rat colon carcinoma cells decreases their interaction with fibronectin. J Cell Biochem 1996; 62:40.
29. 1 integrin in collagen. J Biol Chem 1991; 266:7363.
30. LANGUINO LR, GELSEN KR, WAYNER E, CARTER WG, ENGVALL E, RUOSLAHTI E. Endothelial cells use α2Β1 integrin as a Iaminin receptor. J Cell Biol 1989; 109: 2455.
31. ELICES MJ, URRY LA, HEMLER ME. Receptor functions for the integrin VLA-3; fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol 1991; 112:169.
32. 1 A-domain is a ligand binding site for collagens and laminin. J Biol Chem 1997; 272:12311.
33. PLATT JL, HOLZKNECHT ZE. Porcine platelet antigens recognized by human xenoreactive natural antibodies. Transplantation 1994; 57:327.
34. PLATT JL, LINDMAN BJ, CHEN H, SPITALNIK SL, BACH FH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50:817.
35. SAADI S, PLATT JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181:21.
36. LUMPUGNANI MG, RESNATI M, DEJANA E, MARCHISIO PC. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol 1991; 112:479.
37. CONFORTI G, DOMINGUEZ-JIMENEZ C, ZANETTI A, GIMBRONE MA, CREMONA O, MARCHISIO PC, DEJANA E. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 1992; 80:437.